Commercial Probiotic Products: A Call for Improved Quality Control. A Position Paper by the ESPGHAN Working Group for Probiotics and Prebiotics

Journal of Pediatric Gastroenterology and Nutrition

Volumn 65, Issue 1, 2017, Pages 117-124

  Kolaček, Sanja ^a   Hojsak, Iva ^a   Berni Canani, Roberto ^b   Guarino, Alfredo ^b   Indrio, Flavia ^c   Orel, Rok ^d   Pot, Bruno ^e   Shamir, Raanan ^f   Szajewska, Hania ^g   Vandenplas, Yvan ^h   Van Goudoever, Johannes ⁱ   Weizman, Zvi ^j  

^a Croatia   (Croatia)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c POLICLINICO   (Italy)

^d UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^f TEL AVIV UNIVERSITY   (Israel)

^g MEDICAL UNIVERSITY OF WARSAW   (Poland)

^h UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

ⁱ EMMA CHILDREN S HOSPITAL   (Netherlands)

^j BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

more..

Author keywords

children; commercial products; food supplement; probiotics; quality control; regulation

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

ARTICLE; BACTERIAL STRAIN; CELL VIABILITY; CLASSIFICATION; CONTAMINATION; DIETARY SUPPLEMENT; HUMAN; LAW; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; SHELF LIFE; TAXONOMY; CONSENSUS DEVELOPMENT; FOOD CONTAMINATION; GLOBAL HEALTH; GOVERNMENT REGULATION; LEGISLATION AND JURISPRUDENCE; PACKAGING; PREVENTION AND CONTROL; STANDARDS;

FOOD CONTAMINATION; GLOBAL HEALTH; GOVERNMENT REGULATION; HUMANS; PROBIOTICS; PRODUCT LABELING; QUALITY CONTROL;

EID: 85017454544     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001603     Document Type: Article

References (56)

1. Embleton ND, Zalewski S, Berrington JE. Probiotics for prevention of necrotizing enterocolitis and sepsis in preterm infants. Curr Opin Infect Dis 2016;29:256-61
2. Fiocchi A, Pecora V, Dahdah L. Probiotics, prebiotics& food allergy prevention: clinical data in children. J Pediatr Gastroenterol Nutr 2016;63(suppl 1):S14-7
3. Rodenas CL, Lepage M, Ngom-Bru C, et al. Effect of formula containing Lactobacillus Reuteri DSM 17938 on fecal microbiota of infants born by cesarean-section. J Pediatr Gastroenterol Nutr 2016;63:681-7
4. Lien TH, Bu LN, Wu JF, et al. Use of Lactobacillus casei rhamnosus to prevent cholangitis in biliary atresia after kasai operation. J Pediatr Gastroenterol Nutr 2015;60:654-8
5. Sanders ME, Merenstein DJ, Ouwehand AC, et al. Probiotic use in atrisk populations. J Am Pharm Assoc (2003) 2016;56:680-6
6. Szajewska H, Canani RB, Guarino A, et al. Probiotics for the prevention of antibiotic-associated diarrhea in children. J Pediatr Gastroenterol Nutr 2016;62:495-506
7. Szajewska H, Guarino A, Hojsak I, et al. Authors' response. J Pediatr Gastroenterol Nutr 2016;62:e12-3
8. Szajewska H, Guarino A, Hojsak I, et al. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 2014;58:531-9
9. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11:506-14
10. Auclair J, Frappier M, Millette M. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K): characterization, manufacture, mechanisms of action, and quality control of a specific probiotic combination for primary prevention of Clostridium difficile infection. Clin Infect Dis 2015;60(suppl 2):S135-43
11. Grzeskowiak L, Isolauri E, Salminen S, et al. Manufacturing process influences properties of probiotic bacteria. Br J Nutr 2011;105: 887-94
12. Nivoliez A, Camares O, Paquet-Gachinat M, et al. Influence of manufacturing processes on in vitro properties of the probiotic strain Lactobacillus rhamnosus Lcr35(R). J Biotechnol 2012;160:236-41
13. Broeckx G, Vandenheuvel D, Claes IJ, et al. Drying techniques of probiotic bacteria as an important step towards the development of novel pharmabiotics. Int J Pharm 2016;505:303-18
14. Alvarez-Calatayud G, Margolles A. Dual-coated lactic acid bacteria: an emerging innovative technology in the field of probiotics. Future Microbiol 2016;11:467-75
15. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006;101:1581-90
16. Ministero della Salute, Commissione unica per la nutrizione e la dietetica. Guidelienes on probiotics and prebiotics. Ministero della salute (online), http://www.salute.gov.it/alimentiParticolariIntegratori/newsAlimentiParticolariIntegratori. jspid=1729&menu=inevidenza&lingua=italiano
17. Health Canada. Accepted claims about nature of probiotic microorganisms in food. Health Canada, http:http://www.inspection.gc.ca/food/labelling/food-labelling-for-industry/health-claims/eng/1392834838383/1392834887794chap=9
18. Hojsak I, Abdovic S, Szajewska H, et al. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 2010;125:e1171-7
19. Hojsak I, Tokic Pivac V, Mocic Pavic A, et al. Bifidobacterium animalis subsp. lactis fails to prevent common infections in hospitalized children: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr 2015;101:680-4
20. Lewis ZT, Shani G, Masarweh CF, et al. Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr Res 2016;79:445-52
21. Vallabhaneni S, Walker TA, Lockhart SR, et al. Notes from the field: fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement-Connecticut, 2014. MMWR Morb Mortal Wkly Rep 2015;64:155-6
22. Huys G, Botteldoorn N, Delvigne F, et al. Microbial characterization of probiotics-advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC). Mol Nutr Food Res 2013;57:1479-504
23. Sohier D, Pavan S, Riou A, et al. Evolution of microbiological analytical methods for dairy industry needs. Front Microbiol 2014;5:16
24. Ercolini D. PCR-DGGE fingerprinting: novel strategies for detection of microbes in food. J Microbiol Methods 2004;56:297-314
25. Sule J, Korosi T, Hucker A, et al. Evaluation of culture media for selective enumeration of bifidobacteria and lactic acid bacteria. Braz J Microbiol 2014;45:1023-30
26. Tuomola E, Crittenden R, Playne M, et al. Quality assurance criteria for probiotic bacteria. Am J Clin Nutr 2001;73:393S-403S
27. Davis C. Enumeration of probiotic strains: review of culture-dependent and alternative techniques to quantify viable bacteria. J Microbiol Methods 2014;103:9-17
28. Markiewicz L, Biedrzycka E. Identification of Lactobacillus and Bifidobacterium species with PCR applied to quality control of fermented dairy beverages. Pol J Food Nutr Sci 2005;14/55:359-65
29. Masco L, Huys G, De Brandt E, et al. Culture-dependent and cultureindependent qualitative analysis of probiotic products claimed to contain bifidobacteria. Int J Food Microbiol 2005;102:221-30
30. Huys G, Vancanneyt M, D'haene K, et al. Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use. Res Microbiol 2006;157:803-10
31. Duc Le H, Hong HA, Barbosa TM, et al. Characterization of Bacillus probiotics available for human use. Appl Environ Microbiol 2004;70:2161-71
32. Temmerman R, Scheirlinck I, Huys G, et al. Culture-independent analysis of probiotic products by denaturing gradient gel electrophoresis. Appl Environ Microbiol 2003;69:220-6
33. Sanders ME. Probiotics: definition, sources, selection, and uses. Clin Infect Dis 2008;46(suppl 2):S58-61
34. Federal Regulation of Probiotics: An Analysis of the. Existing Regulatory Framework and Recommendations for. Alternative Frameworks. NIH Grant Number:5R01HG005171-02; 2016. http://www.law.umaryland. edu/ProbioticsWhitePaper
35. Health Food Regulatory System in Japan. Available at: https://food. chemlinked.com/chempedia/health-food-regulatory-system-japan
36. FAO/WHO. Food and Agriculture Organization-World Health Organization. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. 202
37. Food Products Directive and Regulation. Regulation 178/2002/EC; directive 2000/13/EU
38. EU-European Union. Regulation (EC) No. 1924/2006 of the European Parliament ad of the Council of 20 December 2006 on nutritional and health claims made on foods. OJ L 404, 30.12.2006, 9-25
39. FAQ on Nutrition and Health Claims, EFSA, Http://www.efsa.europa. eu/en/fasq/faqnutrition.htm
40. Donovan SM, Schneeman B, Gibson GR, et al. Establishing and evaluating health claims for probiotics. Adv Nutr 2012;3:723-5
41. US Food and Drug Administration. Current Good Manufacturing Practice in Manufacturing, Packaging, Labelling, or Holding Operation for Dietary Supplements, 2007
42. Canganella F, Paganini S, Ovidi M, et al. A microbiology investigation on probiotic pharmaceutical products used for human health. Microbiol Res 1997;152:171-9
43. Drago L, Rodighiero V, Celeste T, et al. Microbiological evaluation of commercial probiotic products available in the USA in 2009. J Chemother 2010;22:373-7
44. Fasoli S, Marzotto M, Rizzotti L, et al. Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int J Food Microbiol 2003;82:59-70
45. Theunissen J, Britz TJ, Torriani S, et al. Identification of probiotic microorganisms in South African products using PCR-based DGGE analysis. Int J Food Microbiol 2005;98:11-21
46. Aureli P, Fiore A, Scalfaro C, et al. National survey outcomes on commercial probiotic food supplements in Italy. Int J Food Microbiol 2010;137:265-73
47. Hamilton-Miller JM, Shah S, Smith CT. "Probiotic" remedies are not what they seem. BMJ 1996;312:55-6
48. Marcobal A, Underwood MA, Mills DA. Rapid determination of the bacterial composition of commercial probiotic products by terminal restriction fragment length polymorphism analysis. J Pediatr Gastroenterol Nutr 2008;46:608-11
49. Szajewska H, Fordymacka A, Bardowski J, et al. Microbiological and genetic analysis of probiotic products licensed for medicinal purposes. Med Sci Monit 2004;10:BR346-50
50. Morovic W, Hibberd AA, Zabel B, et al. Genotyping by PCR and highthroughput sequencing of commercial probiotic products reveals composition biases. Front Microbiol 2016;7:1747
51. Hamilton-Miller JM, Shah S, Winkler JT. Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr 1999;2: 223-9
52. Allgeyer LC, Miller MJ, Lee SY. Sensory and microbiological quality of yogurt drinks with prebiotics and probiotics. JDairy Sci 2010;93:4471-9
53. Temmerman R, Pot B, Huys G, et al. Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol 2003;81:1-10
54. De Vecchi E, Nicola L, Zanini S, et al. In vitro screening of probiotic characteristics of some italian products. J Chemother 2008;20:341-7
55. Vanhee LM, Goeme F, Nelis HJ, et al. Quality control of fifteen probiotic products containing Saccharomyces boulardii. J Appl Microbiol 2010;109:1745-52
56. Goldstein EJ, Citron DM, Claros MC, et al. Bacterial counts from five over-the-counter probiotics: are you getting what you paid for Anaerobe 2014;25:1-4.